Orixha Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.34M
- Investors
-
12
Orixha General Information
Description
Developer of a fluid ventilation device designed to offer cooling after cardiac arrest. The company's device transforms the patient's lungs into an extremely efficient heat exchange chamber with the blood, enabling doctors to protect vital organs from the sequelae caused by reperfusion.
Contact Information
Website
www.orixha.comCorporate Office
- 7 Avenue Du Général De Gaulle
- 94700 Maisons-Alfort
- France
Corporate Office
- 7 Avenue Du Général De Gaulle
- 94700 Maisons-Alfort
- France
Orixha Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 10-Apr-2024 | $4.34M | Completed | Generating Revenue | ||
| 8. Early Stage VC | 01-Oct-2022 | Completed | Generating Revenue | |||
| 7. Grant | 15-Jun-2022 | Completed | Generating Revenue | |||
| 6. Seed Round | 10-Dec-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Sep-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 02-Jun-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Orixha Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Orixha Patents
Orixha Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4647097-A1 | Liquid ventilation connector | Inactive | 07-May-2024 | ||
| WO-2025233308-A1 | Liquid ventilation connector | Pending | 07-May-2024 | ||
| CA-3215042-A1 | Total liquid ventilation system and method | Pending | 23-Apr-2021 | ||
| EP-4079355-A1 | Total liquid ventilation system and method | Active | 23-Apr-2021 | ||
| EP-4079355-B1 | Total liquid ventilation system and method | Active | 23-Apr-2021 | A61M16/0054 |
Orixha Signals
Orixha Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Activation | Corporation | Minority | ||
| Angels Santé | Angel Group | Minority | ||
| Creative & Crossway | Corporation | Minority |
Orixha FAQs
-
When was Orixha founded?
Orixha was founded in 2018.
-
Where is Orixha headquartered?
Orixha is headquartered in Maisons-Alfort, France.
-
What is the size of Orixha?
Orixha has 10 total employees.
-
What industry is Orixha in?
Orixha’s primary industry is Therapeutic Devices.
-
Is Orixha a private or public company?
Orixha is a Private company.
-
What is Orixha’s current revenue?
The current revenue for Orixha is .
-
How much funding has Orixha raised over time?
Orixha has raised $11.6M.
-
Who are Orixha’s investors?
Bpifrance, European Innovation Council, Activation, Angels Santé, and Creative & Crossway are 5 of 12 investors who have invested in Orixha.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process